Literature DB >> 18651208

Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.

Koji Shiraki1, Noriyuki Takata, Ryusuke Takano, Yoshiki Hayashi, Katsuhide Terada.   

Abstract

PURPOSE: To demonstrate improvement in the dissolution of exemestane and megestrol acetate from cocrystallization using various particle sizes and to investigate the mechanism of the improved dissolution.
METHODS: Cocrystal screening was performed by slurry crystallization. The cocrystals were identified and characterized by powder X-ray diffraction, thermal analysis, and single crystal X-ray diffraction. Different particle sizes of each cocrystal were prepared from organic solutions. Solubility and dissolution rates were evaluated using dissolution tests. Transformation behavior of the cocrystals in suspension was analyzed by PXRD and polarization microscopy.
RESULTS: Two novel cocrystals were obtained: exemestane (EX)/maleic acid (MAL) (cocrystal 1) and megestrol acetate (MA)/saccharin (SA) (cocrystal 2). Cocrystal 1 showed a high dissolution rate even with large particles. Cocrystal 2 showed supersaturation with fine particles. The transformation from cocrystal 1 to EX was observed within 1 min in suspension. Cocrystal 2 was transformed to MA within 2-4 h.
CONCLUSIONS: Cocrystallizations of EX and MA improved initial dissolution rates compared to the respective original crystals. The mechanism of dissolution enhancement varied. With cocrystal 1, fine particle formation resulted in enhancement, whereas with cocrystal 2, enhancement was due to the maintenance of the cocrystal form and rapid dissolution before transformation to the original crystal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651208     DOI: 10.1007/s11095-008-9676-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

1.  Reaction crystallization of pharmaceutical molecular complexes.

Authors:  Naír Rodríguez-Hornedo; Sarah J Nehm; Kurt F Seefeldt; Yomaira Pagan-Torres; Christopher J Falkiewicz
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

2.  Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons.

Authors:  Rina J Chokshi; Hossein Zia; Harpreet K Sandhu; Navnit H Shah; Waseem A Malick
Journal:  Drug Deliv       Date:  2007-01       Impact factor: 6.419

3.  Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.

Authors:  Daniel P McNamara; Scott L Childs; Jennifer Giordano; Anthony Iarriccio; James Cassidy; Manjunath S Shet; Richard Mannion; Ed O'Donnell; Aeri Park
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.

Authors:  Ning Li; M D DeGennaro; W Liebenberg; L R Tiedt; A S Zahr; A S Zahn; M V Pishko; M M de Villiers
Journal:  Pharmazie       Date:  2006-07       Impact factor: 1.267

5.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

Authors:  Julius F Remenar; Sherry L Morissette; Matthew L Peterson; Brian Moulton; J Michael MacPhee; Héctor R Guzmán; Orn Almarsson
Journal:  J Am Chem Soc       Date:  2003-07-16       Impact factor: 15.419

6.  Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.

Authors:  Julius F Remenar; Matthew L Peterson; Peter W Stephens; Zhong Zhang; Yuri Zimenkov; Magali B Hickey
Journal:  Mol Pharm       Date:  2007-05-12       Impact factor: 4.939

7.  Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.

Authors:  K Seefeldt; J Miller; F Alvarez-Núñez; N Rodríguez-Hornedo
Journal:  J Pharm Sci       Date:  2007-05       Impact factor: 3.534

8.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids.

Authors:  Scott L Childs; Leonard J Chyall; Jeanette T Dunlap; Valeriya N Smolenskaya; Barbara C Stahly; G Patrick Stahly
Journal:  J Am Chem Soc       Date:  2004-10-20       Impact factor: 15.419

9.  Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. I: Phenazopyridine.

Authors:  A T Serajuddin; C I Jarowski
Journal:  J Pharm Sci       Date:  1985-02       Impact factor: 3.534

10.  Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.

Authors:  Srinivas Basavoju; Dan Boström; Sitaram P Velaga
Journal:  Pharm Res       Date:  2007-08-17       Impact factor: 4.200

View more
  17 in total

1.  Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development.

Authors:  Makoto Kataoka; Kiyohiko Sugano; Claudia da Costa Mathews; Jing Wen Wong; Kelly Lane Jones; Yoshie Masaoka; Shinji Sakuma; Shinji Yamashita
Journal:  Pharm Res       Date:  2011-12-02       Impact factor: 4.200

2.  Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.

Authors:  Shing Fung Chow; Miles Chen; Limin Shi; Albert H L Chow; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2012-02-23       Impact factor: 4.200

3.  A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.

Authors:  Chao Hong; Yan Xie; Yashu Yao; Guowen Li; Xiurong Yuan; Hongyi Shen
Journal:  Pharm Res       Date:  2014-06-18       Impact factor: 4.200

4.  Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.

Authors:  Taro Kojima; Kenjirou Higashi; Toyofumi Suzuki; Kazuo Tomono; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2012-01-05       Impact factor: 4.200

5.  Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.

Authors:  Karl J Box; John Comer; Robert Taylor; Shyam Karki; Rebeca Ruiz; Robert Price; Nikoletta Fotaki
Journal:  AAPS PharmSciTech       Date:  2015-07-25       Impact factor: 3.246

6.  Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.

Authors:  A V Yadav; A S Shete; A P Dabke; P V Kulkarni; S S Sakhare
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

7.  Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.

Authors:  Luyuan Li; Zunting Pang; Kun Ma; Yuan Gao; Daoyi Zheng; Yuanfeng Wei; Jianjun Zhang; Shuai Qian
Journal:  Pharm Res       Date:  2021-11-02       Impact factor: 4.200

8.  Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.

Authors:  Prabhakar Panzade; Giridhar Shendarkar
Journal:  Turk J Pharm Sci       Date:  2019-07-10

9.  Pharmaceutical Cocrystals and Their Physicochemical Properties.

Authors:  Nate Schultheiss; Ann Newman
Journal:  Cryst Growth Des       Date:  2009-04-20       Impact factor: 4.076

10.  Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.

Authors:  Fahad Mehmood Khan; Mahmood Ahmad; Hafiz Arfat Idrees
Journal:  Drug Des Devel Ther       Date:  2020-10-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.